Yixin Jin
- Researcher; PhD
Publications 2024
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers
Int J Mol Sci, 25 (1)
DOI 10.3390/ijms25010586, PubMed 38203757
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586
Int J Mol Sci, 25 (18)
DOI 10.3390/ijms251810024, PubMed 39337718
Publications 2023
Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy
Biomedicines, 11 (2)
DOI 10.3390/biomedicines11020459, PubMed 36830995
Publications 2022
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
Mol Ther Oncolytics, 26, 189-206
DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
Publications 2021
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression
Cancer Res, 81 (15), 4066-4078
DOI 10.1158/0008-5472.CAN-20-3956, PubMed 34183356
Publications 2019
Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
Oncogene, 38 (35), 6301-6318
DOI 10.1038/s41388-019-0879-2, PubMed 31312022
Publications 2016
Essential role of Cdc42 in cardiomyocyte proliferation and cell-cell adhesion during heart development
Dev Biol, 421 (2), 271-283
DOI 10.1016/j.ydbio.2016.12.012, PubMed 27986432
Publications 2014
Stromal interaction molecule 1 (STIM1) and Orai1 mediate histamine-evoked calcium entry and nuclear factor of activated T-cells (NFAT) signaling in human umbilical vein endothelial cells
J Biol Chem, 289 (42), 29446-56
DOI 10.1074/jbc.M114.578492, PubMed 25190815
Publications 2013
Deletion of Cdc42 enhances ADAM17-mediated vascular endothelial growth factor receptor 2 shedding and impairs vascular endothelial cell survival and vasculogenesis
Mol Cell Biol, 33 (21), 4181-97
DOI 10.1128/MCB.00650-13, PubMed 23979594
Inactivation of Cdc42 in neural crest cells causes craniofacial and cardiovascular morphogenesis defects
Dev Biol, 383 (2), 239-52
DOI 10.1016/j.ydbio.2013.09.013, PubMed 24056078
ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling
Sci Signal, 6 (262), ra11
DOI 10.1126/scisignal.2003087, PubMed 23405013
Publications 2012
Isolation and characterization of vascular endothelial cells from murine heart and lung
Methods Mol Biol, 843, 147-54
DOI 10.1007/978-1-61779-523-7_14, PubMed 22222529
Inactivation of Cdc42 in embryonic brain results in hydrocephalus with ependymal cell defects in mice
Protein Cell, 4 (3), 231-42
DOI 10.1007/s13238-012-2098-2, PubMed 23150167
Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1
Traffic, 13 (5), 650-64
DOI 10.1111/j.1600-0854.2012.01341.x, PubMed 22321063
Publications 2011
The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein
Cell Signal, 23 (11), 1758-66
DOI 10.1016/j.cellsig.2011.06.010, PubMed 21745565
Translocation of exogenous FGF1 into cytosol and nucleus is a periodic event independent of receptor kinase activity
Exp Cell Res, 317 (7), 1005-15
DOI 10.1016/j.yexcr.2011.01.003, PubMed 21223966
Publications 2007
Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK
Oncogene, 26 (44), 6372-85
DOI 10.1038/sj.onc.1210473, PubMed 17533378
Publications 2006
IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids
J Leukoc Biol, 80 (2), 287-97
DOI 10.1189/jlb.1205751, PubMed 16769764
Publications 2005
Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis
J Immunol, 174 (1), 270-6
DOI 10.4049/jimmunol.174.1.270, PubMed 15611249
Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor
Eur J Immunol, 35 (9), 2699-708
DOI 10.1002/eji.200526129, PubMed 16078278
Publications 2004
D-galactosyl-beta1-1'-sphingosine and D-glucosyl-beta1-1'-sphingosine induce human natural killer cell apoptosis
Biochem Biophys Res Commun, 320 (3), 810-5
DOI 10.1016/j.bbrc.2004.06.027, PubMed 15240120
Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells
Cell Signal, 16 (9), 991-1000
DOI 10.1016/j.cellsig.2004.02.001, PubMed 15212760
Publications 2003
Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation
Blood, 101 (12), 4909-15
DOI 10.1182/blood-2002-09-2962, PubMed 12586615
Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization
Eur J Immunol, 33 (8), 2083-9
DOI 10.1002/eji.200323711, PubMed 12884281
Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4
Cancer Biother Radiopharm, 18 (5), 829-40
DOI 10.1089/108497803770418373, PubMed 14629831